Diabetic retinopathy, now termed “diabetic retinal disease” (DRD), impacts the entire neurovascular retina1 and affects 103 million persons worldwide2 despite widespread availability to laser and anti-vascular endothelial growth factor (VEGF) treatments. The gene discussed is VEGFA; the disease is dystonia 5.